On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Video: Workplace ICE Raids Are Surging—Here’s How Employers Can Prepare - Employment Law This Week
- SCOTUS Levels the Field for “Reverse” Discrimination: Potential Consequences
- Video: DOL Restructures - OFCCP on the Chopping Block as Opinion Letters Expand - Employment Law This Week
- Hot Topics in Employee Benefits: A Primer for In-House Lawyers
- Video: Abortion Protections Struck Down, LGBTQ Harassment Guidance Vacated, EEO-1 Reporting Opens - Employment Law This Week